STI Stock Trade Intelligence
DVL

DORSAVI LTD

Health Care · ASX:DVL
$0.0220
0.00%
Market cap
$27M
Turnover
$6,351
Last price
$0.0220
Day change
0.00%
Announcements
22
Range, past year
Open 0.049 · Low 0.007 · Now 0.022 · High 0.069
Open DVL in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.

DVL momentum and trend analysis

Our analysis
Independent analysis generated by Stock Trade Intelligence as at 2026-10-13.
Momentum quality
24/100
Wyckoff phase
Downtrend3d
Trend stage
Breakdown
1 Day
+0.0%
1 Week
-8.3%
1 Month
-8.3%
1 Year
-60.7%
RSI
35
Avg daily range
6.4%

DORSAVI LTD scores 24 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.

On the Wyckoff cycle it sits in Downtrend, where it has been for 3 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.

Against the wider market it is currently underperforming and the institutional accumulation signal reads low.

Points to watch
  • 60d drawdown -21.4%
  • High volatility (ATR 6.4%)
  • Thin liquidity
  • Risk rating: Very High
  • Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highs

DVL announcements

Recent price-sensitive releases.
  • 2026-10-06 dorsaVi Raises A$3M for Robotics Strategy and RRAM Tape-Out Placement | Trading Halt Lifted
  • 2026-10-02 Trading Halt Trading Halt
  • 2026-09-21 dorsaVi targets humanoid robotics with neuromorphic IP, RRAM Progress Report
  • 2026-09-14 dorsaVi Characterises RRAM Energy Efficiency for Physical AI Progress Report
  • 2026-08-31 DVL June 2026 Appendix 4E and Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
  • 2026-08-24 dorsaVi Completes CMOS Fabrication for RRAM Validation Chip Progress Report
  • 2026-08-12 dorsaVi Commences Fabrication of First RRAM-CMOS Chip Progress Report
Get the daily briefing The day's price-sensitive announcements, ranked by what actually moved, with our own momentum and cycle read on each.